![N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-p…](https://static.cymitquimica.com/cas-image/thumb-webp/393765-n-4-1-26-difluorophenyl-methyl-5-dimethylamino-methyl-1234-tetrahydro-3-6-methoxy-3-pyridazinyl-24-dioxothieno-23-d-pyrimidin-6-yl-phenyl-n-methoxyurea.webp)
CAS 737789-87-6
:N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N′-methoxyurea
Description:
N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N′-methoxyurea, with CAS number 737789-87-6, is a complex organic compound characterized by its unique structural features, including multiple functional groups and a fused ring system. This compound exhibits properties typical of urea derivatives, which often include biological activity, making it of interest in pharmaceutical research. The presence of difluorophenyl and methoxy groups suggests potential lipophilicity, which can influence its solubility and permeability in biological systems. The tetrahydro and thieno[2,3-d]pyrimidine moieties contribute to its structural diversity, potentially impacting its interaction with biological targets. Additionally, the dimethylamino group may enhance its pharmacological profile by improving binding affinity or modulating activity. Overall, this compound's intricate structure and functionalization indicate its potential utility in medicinal chemistry, particularly in the development of therapeutic agents.
Formula:C29H27F2N7O5S
InChI:InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)
InChI key:InChIKey=AOMXMOCNKJTRQP-UHFFFAOYSA-N
SMILES:C(N1C2=C(C(CN(C)C)=C(S2)C3=CC=C(NC(NOC)=O)C=C3)C(=O)N(C1=O)C4=CC=C(OC)N=N4)C5=C(F)C=CC=C5F
Synonyms:- 1-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea
- N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N′-methoxyurea
- Orgovyx
- Rvt 601
- TAK-385,Relugolix
- Tak-385
- Urea, N-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N′-methoxy-
- Relugolix
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
1-(4-(1-(2,6-Difluorobenzyl)-5-((Dimethylamino)Methyl)-3-(6-Methoxypyridazin-3-Yl)-2,4-Dioxo-1,2,3,4-Tetrahydrothieno[2,3-D]Pyrimidin-6-Yl)Phenyl)-3-Methoxyurea
CAS:1-(4-(1-(2,6-Difluorobenzyl)-5-((Dimethylamino)Methyl)-3-(6-Methoxypyridazin-3-Yl)-2,4-Dioxo-1,2,3,4-Tetrahydrothieno[2,3-D]Pyrimidin-6-Yl)Phenyl)-3-MethoxyureaFormula:C29H27F2N7O5SPurity:98%Molecular weight:623.63Relugolix-d6
CAS:Formula:C29H21D6F2N7O5SColor and Shape:White To Off-White SolidMolecular weight:629.67Relugolix (Standard)
CAS:Relugolix (Standard) is a reference standard for research and analysis in studies involving Relugolix. Relugolix (RVT-601) is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity. Relugolix competitively binds to and blocks the GnRH receptor in the anterior pituitary gland, which both prevents GnRH binding to the GnRH receptor and inhibits the secretion and release of both luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone from Leydig cells in the testes. Since testosterone is required to sustain prostate growth, reducing testosterone levels may inhibit hormone-dependent prostate cancer cell proliferation.Formula:C29H27F2N7O5SMolecular weight:623.63Relugolix
CAS:1-(4-(1-(2,6-Difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyureaFormula:C29H27F2N7O5SPurity:98%Molecular weight:623.63Relugolix
CAS:Relugolix (RVT-601) is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, withFormula:C29H27F2N7O5SPurity:98.64% - 99.97%Color and Shape:White SolidMolecular weight:623.63N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxyurea
CAS:Formula:C29H27F2N7O5SPurity:98%Color and Shape:SolidMolecular weight:623.6304
![N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-p…](https://static.cymitquimica.com/products/IN/thumb/DA00FC12.jpg)